Articles with "laba lama" as a keyword



Photo by iraj83 from unsplash

Combinatie LABA-LAMA iets effectiever bij COPD

Sign Up to like & get
recommendations!
Published in 2019 at "Huisarts en wetenschap"

DOI: 10.1007/s12445-019-0213-9

Abstract: SamenvattingVoor COPD zijn veel inhalatiemedicijnen beschikbaar, maar bij matige en ernstige COPD is de combinatie LABA (langwerkende bèta-2-antagonisten)-LAMA (langwerkende muscarine-antagonisten) iets effectiever dan andere medicatie. Dat blijkt uit een analyse van trials waarin LABA, LAMA,… read more here.

Keywords: copd; iets effectiever; laba lama; combinatie laba ... See more keywords

GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.

Sign Up to like & get
recommendations!
Published in 2017 at "Respiratory medicine"

DOI: 10.1016/j.rmed.2017.08.008

Abstract: INTRODUCTION The 2017 update to the Global Initiative for Obstructive Lung Disease (GOLD) strategy document includes recommendations for treatment intensification or step-down in chronic obstructive pulmonary disease (COPD), although recognises that limited supporting information is… read more here.

Keywords: laba lama; treatment; study; gold ... See more keywords
Photo from wikipedia

COPD maintenance medication is linked to left atrial size: Results from the COSYCONET cohort.

Sign Up to like & get
recommendations!
Published in 2021 at "Respiratory medicine"

DOI: 10.1016/j.rmed.2021.106461

Abstract: BACKGROUND Lung function impairment in COPD is known to be related to reductions of left heart size, while short-term interventional trials with bronchodilators showed positive effects on cardiac parameters. We investigated whether COPD maintenance therapy… read more here.

Keywords: laba lama; copd maintenance; ics laba; medication ... See more keywords
Photo from wikipedia

Variation in costs due to virtual switching from free- to fixed-triple LABA/LAMA/ICS combinations among COPD patients: an analysis using a primary care database

Sign Up to like & get
recommendations!
Published in 2022 at "Current Medical Research and Opinion"

DOI: 10.1080/03007995.2022.2129229

Abstract: Abstract Chronic obstructive pulmonary disease (COPD) is a condition with a relevant clinical and economic burden. Only 10% to 40% of COPD patients reporting a regular use of respiratory medications, including those who suffered from… read more here.

Keywords: triple laba; copd patients; lama ics; fixed triple ... See more keywords
Photo by finnnyc from unsplash

Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for COPD: A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice Guideline.

Sign Up to like & get
recommendations!
Published in 2020 at "Annals of the American Thoracic Society"

DOI: 10.1513/annalsats.201912-915oc

Abstract: RATIONALE There is uncertainty on the optimal first-line therapy for symptomatic COPD. Long-acting beta-2-receptor agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) have long been mainstays of treatment, though it is still not clear if dual… read more here.

Keywords: laba lama; therapy; lama; lama monotherapy ... See more keywords
Photo from wikipedia

Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study

Sign Up to like & get
recommendations!
Published in 2021 at "Frontiers in Pharmacology"

DOI: 10.3389/fphar.2021.753653

Abstract: Purpose: This real-world study evaluated the effectiveness of different inhalation therapies in patients with symptomatic chronic obstructive pulmonary disease (COPD) in China and also explored the relevant factors that influence the effectiveness of inhalation therapy.… read more here.

Keywords: inhalation therapy; laba lama; study; patients treated ... See more keywords
Photo by videoqueenstl from unsplash

In COPD, new use of long-acting bronchodilators was linked to CV events at 30 days, but not >30 days

Sign Up to like & get
recommendations!
Published in 2018 at "Annals of Internal Medicine"

DOI: 10.7326/acpjc-2018-168-8-047

Abstract: Question In patients with chronic obstructive pulmonary disease (COPD), do long-acting 2-agonists (LABAs) or long-acting muscarinic antagonists (LAMAs) increase risk for cardiovascular (CV) events? Methods Design Nested casecontrol study using data from the Taiwan National… read more here.

Keywords: use; long acting; laba lama; new use ... See more keywords